Ginkgo Biloba’s Neuroprotective Potential in Alzheimer’sDementia

Abstract

Alzheimer's disease (AD), which is characterized by increasing cognitive impairment and neuroinflammation, is a growing global health concern. Ginkgo biloba extract (standardized as EGb 761) has attracted a lot of interest among botanical therapies because to its many neuroprotective qualities. The main reason for its effectiveness is the combination of terpene lactones and flavonoid glycosides, which work in concert to tackle the underlying pathophysiology of dementia via multiple different pathways. Ginkgo biloba's strong antioxidant capability is the primary basis of its neuroprotective potential. The extract reduces the oxidative stress that usually precedes neuronal death in AD patients by scavenging reactive oxygen species (ROS) and increasing the activity of superoxide dismutase. Additionally, Ginkgo biloba exhibits a special capacity to maintain mitochondrial integrity, which stabilizes cellular energy production and prevents pro-apoptotic signals from being activated. In addition to protecting cells, the extract modifies the amyloid cascade by preventing peptides from aggregating into harmful oligomers, hence lowering the "plaque load" that interferes with synaptic transmission.

According to clinical studies, ginkgo biloba is especially useful for stabilizing or delaying the deterioration of cognitive abilities and enhancing the ability of people with mild-to-moderate dementia to perform activities of daily living (ADL). The clinical data is still a little inconsistent because of variations in extract concentrations and patient demographics, even though it also improves cerebral microcirculation and lowers blood viscosity, offering a secondary vascular advantage. Ginkgo biloba ultimately functions as a clinically useful, well-tolerated adjunct therapy that tackles the complexity of neurodegeneration through a multi-target pharmacological approach, even though it is not a disease-modifying solution.